EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma

Clinical trial NCT07619950 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07619950
Sponsor: Yonsei University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms of Bone and Articular Cartilage With Unspecified Anatomical Site

Start date: 2026-07-01
Primary completion: 2028-11-30
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.